Page 42 - Anjali Singh

India can become $1 trn export-led automotive hub by 2035: Report

India is the fourth-largest global automotive market, generating $250 billion in FY23 and contributing 7.3 per cent to the national GDP

Schedule M likely to be revised to bring it closer to WHO standards

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India

Agilus Diagnostics files for IPO to raise funds via 142.3 mn shares

The diagnostics giant partners with ICICI Securities, Axis Capital, and Citigroup for public offering, aiming to sell equity shares held by key investors

Lupin gets EIR Status from US FDA for Nagpur Unit-1 manufacturing facility

The EIR was issued following the facility's inspection conducted in July 2023

BDR Pharma launches generic drug for fungal infections at 1/3rd the cost

Zisavel capsules will be available as 100 mg capsules and will be priced at Rs 7,992 for 7 capsules

Don't miss a beat: Heart ailments in young women on the rise, shows data

Digital healthcare platform Practo saw a 215 per cent increase in total consultations related to cardiovascular health

Glenmark, Cosmo partner to bring acne treatment Winlevi to Europe, S Africa

This agreement grants Glenmark the exclusive right to commercialise Winlevi in 15 EU countries, South Africa, and the UK

New National Medical Commission tag no game changer for medical students

Had the recognition not come, then students from several colleges may have found it difficult to appear for the USMLE if their college was not recognised by the WFME

Lupin inks pact to acquire five legacy brands from Menarini Group

Lupin has secured the rights to five brands - Piclin, Menoctyl, Sucramal O, Pyridium and Distaclor

Cipla's US subsidiary InvaGen gets 5 inspectional observations from USFDA

The inspection was a routine current Good Manufacturing Practices (cGMP) inspection and a Pre-Approval Inspection (PAI) for a site transfer product within InvaGen

Ipca Laboratories acquires 19.29% stake in Unichem through open offer

Ipca shares ended the day's trade at Rs 898 apiece, down 1.6 per cent on BSE

Labour dispute halts production at Apollo Tyres Limda plant in Gujarat

Apollo Tyres also revealed that there is no material impact on the operations at this stage

Biocon Biologics gains EU approval for Aflibercept biosimilar, YESAFILI

According to market research firm IQVIA, Aflibercept generated about $1.8 billion in annual sales in the EU in 2022

Asia Healthcare Holdings acquires majority stake in AINU, invests 600 cr

This move signifies AHH's entry into the fields of urology and nephrology, marking its expansion into a fourth speciality

Indian pharma Industry to log 8-10% revenue growth in FY24: Report

Drugs in the National List of Essential Medicines contribute 17% of revenue: ICRA

Health services firm CureBay plans expansion in rural Odisha, Chhattisgarh

Startup has raised Rs 61 crore in financing from Elevar Equity, Incred and angel investors

Patient Groups raise concerns over proposed draft of patent rules

Public health experts concerned changes could make it more difficult to access affordable medicines

Qure.ai, PATH India partner to provide TB, Covid screening in Maharashtra

qXR uses deep learning to analyse chest X-rays and identify potential abnormalities. This can help to improve the accuracy and speed of TB and COVID-19 diagnosis

Classic Legends to invest Rs 1,000 cr in 3 years to increase production

Mahindra group Chairman Anand Mahindra said the bikes belonged to the 'classic retro' segment, which had a growing customer base

IndiaRF invests Rs 525 crore in Ivy Health and Life Sciences Private Ltd

Financial advisors for this transaction included O3 Capital, representing IndiaRF, and Unaprime Investment Advisors, advising Ivy